Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-25-022518

Director acquired 2,181 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Holder Michael Director 2025-08-18 Option exercise +2,181 10,178 D
Derivatives
Holder Michael Director 2025-08-18 Option exercise · Restricted Stock Units −2,181 16,000 D
Loading xslF345X05/form4-08202025_090800.xml…